iTeos Therapeutics, Inc. announced the promotion of Yvonne McGrath, Ph.D., to chief scientific officer.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
16.23 USD | -0.43% | -2.81% | +48.22% |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+48.22% | 605M | |
+18.15% | 124B | |
+18.02% | 112B | |
+4.63% | 22.94B | |
-9.86% | 17.02B | |
-16.45% | 16.88B | |
-39.94% | 16.87B | |
+2.80% | 13.63B | |
+27.39% | 11.61B | |
+106.26% | 10.31B |
- Stock Market
- Equities
- ITOS Stock
- News iTeos Therapeutics, Inc.
- ITeos Therapeutics, Inc. Promotes Yvonne McGrath, Ph.D. to Chief Scientific Officer